Factors affecting decisions of an HMO Drug Exemptions Committee on individual patient requests for coverage of non-formulary drugs
Abstract Background In Israel, coverage of health needs is delivered by four health maintenance organizations (HMOs), which are budgeted by the government according to the recommendations of the National Drug Formulary (NDF) Committee. For medications not listed in the NDF, individuals may request t...
Saved in:
Main Authors: | Yael Topol (Author), Lior Weiss (Author), Yossi Lomnicky (Author), Inbal Yifrach-Damari (Author), Noa Markovits (Author), Ronen Loebstein (Author), Itai Gueta (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patients' knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee
by: Pia Bastholm-Rahmner, et al.
Published: (2018) -
Neonatal Drug Formularies-A Global Scope
by: Dotan Shaniv, et al.
Published: (2023) -
Adverse childhood experiences and prescription drug use in a cohort study of adult HMO patients
by: Dube Shanta R, et al.
Published: (2008) -
The use of antimicrobial drugs in preterm newborn: the experience of creating the formulary
by: M. A. Ivzhits, et al.
Published: (2018) -
Therapeutic exemption in sports and drug abuse aimed at improving sports performance
by: Stojmenović Dragutin, et al.
Published: (2021)